AiRato Overview

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $4.36M

  • Investors
  • 17

AiRato General Information

Description

Developer of radiotherapy AI technology designed to enhance the effectiveness and efficiency of advanced radiation treatments. The company's platform utilizes artificial intelligence trained on clinical data from domestic centers to automate key processes in intensity-modulated radiation therapy, enabling cancer patients to access precise and less physically taxing treatments while supporting clinicians in delivering improved therapeutic outcomes with reduced operational workload.

Contact Information

Website
www.airato.jp
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 468-1 Aramaki Aoba, Aoba-ku
  • Inside the Aobayama Garage, Materials Innovation Center, Tohoku University
  • Sendai, Miyagi 980-8572
  • Japan
Primary Industry
Outcome Management (Healthcare)
Other Industries
Diagnostic Equipment
Corporate Office
  • 468-1 Aramaki Aoba, Aoba-ku
  • Inside the Aobayama Garage, Materials Innovation Center, Tohoku University
  • Sendai, Miyagi 980-8572
  • Japan

AiRato Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AiRato Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Early Stage VC 24-Jun-2025 $4.36M Completed Generating Revenue
6. Accelerator/Incubator 19-Jun-2025 Completed Generating Revenue
5. Accelerator/Incubator 01-Jan-2025 Completed Generating Revenue
4. Accelerator/Incubator Completed Generating Revenue
3. Accelerator/Incubator 29-Oct-2024 Completed Generating Revenue
2. Seed Round 30-Apr-2024 $780K $780K Completed Generating Revenue
1. Accelerator/Incubator 01-Apr-2021 Completed Startup
To view AiRato’s complete valuation and funding history, request access »

AiRato Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Class B
Class A
To view AiRato’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

AiRato Patents

AiRato Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026164230-A1 Information processing method, computer program, and information processing device Pending 03-Feb-2025
JP-2026131357-A Information processing methods, computer programs, and information processing devices. Pending 03-Feb-2025
JP-2026114319-A Radiation therapy planning support system, radiation therapy planning support program, and radiation therapy planning support method Pending 26-Dec-2024
WO-2026140703-A1 Radiotherapy planning assistance system, radiotherapy planning assistance program, and radiotherapy planning assistance method Pending 26-Dec-2024
WO-2025183054-A1 Dose distribution generation method, program, deep learning device, trained model, and dose distribution generation system Pending 29-Feb-2024
To view AiRato’s complete patent history, request access »

AiRato Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AiRato Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
77 Capital Corporate Venture Capital Minority
Capital Medica Ventures Corporate Venture Capital Minority
Mitsui Sumitomo Kaijo Capital Corporate Venture Capital Minority
Nissay Capital Venture Capital Minority
SMBC Venture Capital Corporate Venture Capital Minority
You’re viewing 5 of 17 investors. Get the full list »

AiRato FAQs

  • Where is AiRato headquartered?

    AiRato is headquartered in Sendai, Japan.

  • What is the size of AiRato?

    AiRato has 10 total employees.

  • What industry is AiRato in?

    AiRato’s primary industry is Outcome Management (Healthcare).

  • Is AiRato a private or public company?

    AiRato is a Private company.

  • What is the current valuation of AiRato?

    The current valuation of AiRato is .

  • What is AiRato’s current revenue?

    The current revenue for AiRato is .

  • How much funding has AiRato raised over time?

    AiRato has raised $5.14M.

  • Who are AiRato’s investors?

    77 Capital, Capital Medica Ventures, Mitsui Sumitomo Kaijo Capital, Nissay Capital, and SMBC Venture Capital are 5 of 17 investors who have invested in AiRato.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process